FDA’s Footdragging Hurts Canada’s Biotech Firms
TORONTO (Reuters) - Canadian biotechnology companies have
joined a chorus of their global counterparts to rail against
the U.S. Food and Drug Administration’s tardiness in approving
new drugs.
Insurances & Business
News Economy Business Investment Banks Credits
Leave a Reply »»
Similar/Related/News:
- Pfizer Invests $300 Mln in Irish Biotech Facility LONDON (Reuters) - Pfizer Inc <PFE.N>, the world's biggest drugmaker, is to invest 190 million euros ($297 million) establishing a new biote...
- Canada’s Hudson’s Bay Co Says CEO Jerry Zucker Dies MONTREAL (Reuters) - Hudson's Bay Co. said that its governor and chief executive Jerry Zucker died on Saturday of cancer....
- U.S. Consulting Firms See Gains From Economy’s Woes BANGALORE (Reuters) - As the nearly year-old credit crisis threatens to send the U.S. economy into a recession, a group of small- and medium-sized...
- More Firms Pull Asian IPOs as Markets Slide HONG KONG/SINGAPORE (Reuters) - Two more firms shelved plans for initial public offerings (IPOs) in Asia, adding further gloom to a market which r...
- Diesel to be made from Brazil sugarcane (AP) A U.S. biotech company is teaming up with Brazilian ethanol producers to turn sugarcane into diesel fuel in a joint venture that could churn out 1 bil...
- Stryker’s Biotech Unit Gets FDA Warning Letter CHICAGO (Reuters) - Stryker Corp <SYK.N> said on Friday its biotechnology division received a warning letter from U.S. health regulators reg...
- Analysts Mixed on Takeda’s $8.8 Billion Millennium Buy TOKYO (Reuters) - Shares in top Japanese drug maker Takeda Pharmaceutical Co <4502.T> fell 2 percent on Friday, a day after it said it would...
- Cell Genesys shares jump on as 1Q results top Wall Street (AP) Shares of Cell Genesys Inc. jumped Friday after the biotech company reported a narrower first-quarter than Wall Street expected....